Faecal immunoreactive lipase: a simple diagnostic test for cystic fibrosis

1998 ◽  
Vol 157 (4) ◽  
pp. 282-286 ◽  
Author(s):  
R. Münch ◽  
C. P. Brägger ◽  
J. Altorfer ◽  
B. Hoppe ◽  
D. H. Shmerling ◽  
...  
2017 ◽  
Vol 16 ◽  
pp. S18
Author(s):  
A.S. Ramalho ◽  
P. Peetermans ◽  
M. Nobens ◽  
M. Ferrant ◽  
M. Proesmans ◽  
...  

2012 ◽  
Vol 48 (3) ◽  
pp. 229-235 ◽  
Author(s):  
Malena Cohen-Cymberknoh ◽  
Yasmin Yaakov ◽  
David Shoseyov ◽  
Eyal Shteyer ◽  
Edna Schachar ◽  
...  

2002 ◽  
Vol 141 (2) ◽  
pp. 0295-0296 ◽  
Author(s):  
Erol A. Gaillard ◽  
Nigel J. Shaw ◽  
Nim V. Subhedar ◽  
Helen L. Wallace ◽  
Kevin W. Southern

2021 ◽  
Vol 8 ◽  
Author(s):  
Ágnes Rita Martonosi ◽  
Alexandra Soós ◽  
Zoltán Rumbus ◽  
Péter Hegyi ◽  
Vera Izsák ◽  
...  

Background and Aims: Cystic fibrosis-related liver disease (CFLD) is one of the leading causes of morbidity and mortality in cystic fibrosis (CF). Several non-invasive diagnostic methods have been proposed as screening tools for CFLD. Our aim was to rank all available non-invasive modalities for diagnostic performance.Methods: A systematic search was performed in five medical databases to find studies which reported on any single or composite non-invasive diagnostic test (as an index test) compared to the Debray, the EuroCare or the Colombo criteria (as a reference standard). Ranking was carried out with a Bayesian diagnostic test accuracy network meta-analysis based on superiority indices, calculated for pooled sensitivity (Se) and specificity (Sp) with a 95% confidence interval (CI). The study was registered under CRD42020155846 in PROSPERO.Results: Fifteen studies with 15 index tests and a combination of them were included. The New criteria proposed by Koh et al. – which represent a composite diagnostic definition for CFLD including liver biochemistry, ultrasonography, transient elastography and fibrosis markers—had the best performance for detecting CFLD (Se:94%[CI:58–100], Sp:72%[CI:52–84]); while transient elastography (Se:65%[CI:56–74], Sp:88%[CI:84–91]) and a combination of it with a tissue inhibitor of metalloproteinase-4 measurement (Se:78%[CI:30–100], Sp:64%[CI:18–95%]) proved to be the second and third best options, respectively. In the imaging techniques subgroup, transient elastography (Se:66%[CI:57–72], Sp:88%[CI:85–91%]), acoustic radiation force impulse in the right lobe (Se:54%[CI:33–74], Sp:88%[CI:66–96]) and that in the left lobe (Se:55%[CI:23–81], Sp:82%[CI:50–95]) were ranked the highest. Comparing biochemical markers/fibrosis indices, the measurement of the Forns index (Se:72%[CI:25–99], Sp:63%[CI:16–94]), the aspartate aminotransferase-to-platelet ratio (Se:55%[CI:41–68], Sp:83%[CI:66–89]) and alkaline phosphatase (Se:63%[CI:18–93], Sp:64%[CI:19–95]) were ranked the highest.Conclusion: The New criteria show the best diagnostic performance. In clinical practice, transient elastography seems to be a simple, cheap and non-invasive tool, outperforming imaging, biochemical and fibrosis tests for detecting CFLD. Further studies are needed to validate our findings.


PEDIATRICS ◽  
1962 ◽  
Vol 30 (2) ◽  
pp. 167-171
Author(s):  
HARRY SHWACHMAN

AN INCREASED interest in the physiology of sweating was precipitated by the demonstration of markedly elevated electrolyte levels in sweat of patients with cystic fibrosis. Indeed, the determination of sweat electrolytes has become the most reliable single diagnostic test for cystic fibrosis, replacing the more difficult, time consuming, uncomfortable, and less reliable procedures of duodenal fluid aspiration and assay. The marked reduction or absence of proteolytic activity of duodenal fluid no longer serves as the cornerstone of diagnosis, since fully 15% of patients with cystic fibrosis have sufficient exocrine pancreatic function to yield normal or nearly normal enzyme values. Nevertheless, study of duodenal fluid is still of considerable value when dealing with cases difficult to diagnose, in instances of borderline sweat electrolyte levels, or for special study purposes.


1991 ◽  
Vol 25 (3) ◽  
pp. 422-425 ◽  
Author(s):  
Toni Single ◽  
Richard Leigh Henry

An 11-year-old boy was presented by his father with a long and plausible history of cystic fibrosis. The diagnostic test for cystic fibrosis, the sweat test, was normal and excluded the diagnosis. The medical history was later found to be false, and the child to be well. By definition, the case met the criteria for Munchausen Syndrome by Proxy with fabrication of symptoms on behalf of another in order to deceive medical personnel. Unusual features included the illness chosen, the father as the parent falsifying illness, his failure to pursue unnecessary investigations and treatment, and the ease with which he relinquished the diagnosis of cystic fibrosis.


The Lancet ◽  
1997 ◽  
Vol 350 (9083) ◽  
pp. 1001 ◽  
Author(s):  
Colin Wallis ◽  
Theresa Leung ◽  
David Cubitt ◽  
Anthony Reynolds

Sign in / Sign up

Export Citation Format

Share Document